À la une

Clean Mails – June 2024 – CHO cell

Leveraging CHO cell potential in R&D and cGMP

With 25 years of experience handling hundreds of cell lines, Clean Cells is your reliable partner on both adherent and suspension models with cloning and manufacturing technologies for CHO cell lines. Our extensive portfolio of QC assays also ensures the best level of characterization for the most potent and safe CHO cells, with complementary and novel methods for monoclonal antibody characteriza-tion (ADCC).

Clean Mails – June 2024

Increasing biologics manufacturing capacities

With 23+ years of experience handling hundreds of cell and virus models, Clean Cells has positioned itself as a leader in cell and virus banking, providing complementary characterization and storage services. Our state-of-the-art cGMP facility launched last year welcomes our biologics manufacturing capacities, providing 8 new clean rooms designed for all types of biopharma projects and equiped to meet production specifications for both adherent and suspension cells. A newly implemented cell cloning platform further integrates our capacities, from initial cloning and selection of the most potent cell lines to fully characterized, ready-to-use cGMP cell & virus banks.

Talk Crispr Medicine Conference

Karyotyping and FISH assays a tool to evaluate the genetic stability of your Cell Therapy products

Don't miss the talk given by our expert in cytogenetic, Dr Vasileios GEORGOKAKOS at the Crispr Medicine Conference !

Save the date !

Congresses 2024: meet our teams!

Teams at Clean Cells are traveling the world to attend major conferences and congresses within the biotech sector. As leaders of the biopharma field, our mission and our drive at the Clean Biologics group are to remain both reachable and up-to-date with regards to the latest developments and innovations.

Clean Mails -February 2024

A comprehensive approach to AAV vector testing

With a growing number of GMP and non-GMP assays and methods for AAV vector testing, Clean Cells continues to show flexibility in development and routine application, having partnered with several organizations worldwide to develop serotype-specific assays. Our ability to generate chimeric AAV with a trusted partner and two detection platforms most notably allow us to quickly develop crucial assays such as replication competent AAV (rcAAV) testing for novel serotypes.

Clean Mails – February 2024

Clean Cells, your partner for single cell cloning to cGMP cell banks

As a contract organization specializing in cGMP cell & virus banking and QC testing, Clean Cells knows the importance of qualitative cell line development. We thus implemented Solentim’s VIPS® PRO, a state-of-the-art single cell cloning platform to isolate potent clones and characterize the monoclonality of biotherapeutics producing cell lines, with an increased traceability as part of a regulatory compliant approach.

Communiqué de presse

Clean Cells lance ses nouvelles suites de production, doublant ses capacités

En passant de cinq à neuf suites de production dans son nouveau bâtiment inauguré en janvier 2023, Clean Cells se met en ordre de marche pour répondre à la demande croissante de production et caractérisation de banques de cellules et de virus.


GMP certificate renewal and successful FDA inspection

Quality and regulatory compliance are the pillars of Clean Cells in order to meet the needs of our customers and support them in the successful development of their biological products. 2023 has been full of success for Clean Cells...